Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy
- Resource Type
- Source
- JCO Precision Oncology.
- Subject
Cancer Research Oncology - Language
- ISSN
- 2473-4284